Stimulus Doomed by Diverging Goals of Trump, Pelosi, McConnell

(Bloomberg) — Even with the U.S. still reeling from the coronavirus pandemic, Washington fell short in delivering more stimulus before the election, whipsawed by President Donald Trump and hobbled by the diverging agendas of the top Republican and Democrat in Congress. Now, voters will help decide what happens next.House Speaker Nancy Pelosi, a self-proclaimed “master…

Hedge Funds Are Piling Into Novavax, Inc. (NVAX)

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of…

Canopy Growth Closes Agreements With Big Alcohol Distributors

Canopy Growth Corp. (NYSE: CGC) (TSE: WEED) announced Tuesday a new distribution partnership with two major alcohol distributors: Reyes Beer Division and Manhattan Beer.The company will leverage these partnerships to bring its sports hydration brand, BioSteel, to U.S. consumers in a ready-to-drink format.Earlier this year, BioSteel signed NFL star Patrick Mahomes as an equity partner…

Canopy Growth Closes Agreements With Big Alcohol Distributors

Canopy Growth Corp. (NYSE: CGC) (TSE: WEED) announced Tuesday a new distribution partnership with two major alcohol distributors: Reyes Beer Division and Manhattan Beer.The company will leverage these partnerships to bring its sports hydration brand, BioSteel, to U.S. consumers in a ready-to-drink format.Earlier this year, BioSteel signed NFL star Patrick Mahomes as an equity partner…

AEMD: Advancing The Hemopurifier in Two Feasibility Studies

By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD) is a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and are not addressed with already approved treatments. The company’s lead product, the Hemopurifier®, is a…

Altimmune’s COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside

Shares of Altimmune published positive pre-clinical data for its new single-dose, intranasal COVID-19 vaccine candidate AdCOVID. Shares closed 1.9% higher on Monday.The company stated that the study conducted on two strains of mice demonstrated that its AdCOVID elicited multi-faceted immune activity including serum neutralizing immunity, T cell immunity, and mucosal immunity.According to Altimmune (ALT), “AdCOVID…